Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Steven R Hagen. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Steven R Hagen har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:AMRI / Albany Molecular Research, Inc. | SVP Manufacturing & Pharmaceut | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Steven R Hagen. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Steven R Hagen som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
D - Sale to Issuer | −29 412 | 0 | −100,00 | 3,34 | −98 236 | ||
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
D - Sale to Issuer | −22 889 | 0 | −100,00 | 5,98 | −136 876 | ||
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
D - Sale to Issuer | −16 280 | 0 | −100,00 | 4,70 | −76 516 | ||
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
D - Sale to Issuer | −20 000 | 0 | −100,00 | 11,32 | −226 400 | ||
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
D - Sale to Issuer | −3 750 | 0 | −100,00 | 15,76 | −59 100 | ||
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
D - Sale to Issuer | −3 750 | 0 | −100,00 | 15,76 | −59 100 | ||
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
D - Sale to Issuer | −7 500 | 0 | −100,00 | 15,76 | −118 200 | ||
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
D - Sale to Issuer | −3 750 | 0 | −100,00 | 18,82 | −70 575 | ||
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
D - Sale to Issuer | −43 655 | 0 | −100,00 | 21,75 | −949 496 | ||
2017-09-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
A - Award | 3 138 | 43 655 | 7,74 | ||||
2017-03-06 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −350 | 40 517 | −0,86 | 14,52 | −5 082 | 588 307 | |
2017-02-10 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
A - Award | 29 412 | 29 412 | |||||
2017-02-10 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
A - Award | 4 484 | 40 867 | 12,32 | ||||
2017-02-10 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
A - Award | 5 975 | 36 383 | 19,65 | ||||
2017-02-07 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −488 | 30 408 | −1,58 | 18,52 | −9 038 | 563 156 | |
2017-02-07 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −664 | 30 896 | −2,10 | 18,52 | −12 297 | 572 194 | |
2017-02-07 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −2 291 | 31 560 | −6,77 | 18,52 | −42 429 | 584 491 | |
2017-02-01 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −531 | 33 851 | −1,54 | 18,11 | −9 616 | 613 042 | |
2017-02-01 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −531 | 33 851 | −1,54 | 18,11 | −9 616 | 613 042 | |
2016-12-01 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | −9 000 | 0 | −100,00 | 13,20 | −118 800 | ||
2016-12-01 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −9 000 | 34 913 | −20,50 | 16,71 | −150 390 | 583 396 | |
2016-12-01 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 9 000 | 43 913 | 25,78 | 13,20 | 118 800 | 579 652 | |
2016-11-10 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −785 | 34 913 | −2,20 | 16,79 | −13 180 | 586 189 | |
2016-11-03 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −465 | 35 698 | −1,29 | 15,09 | −7 017 | 538 683 | |
2016-08-10 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 401 | 36 163 | −3,73 | 15,29 | −21 421 | 552 932 | |
2016-05-16 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −2 361 | 37 564 | −5,91 | 12,77 | −30 150 | 479 692 | |
2016-03-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −340 | 39 925 | −0,84 | 15,33 | −5 212 | 612 050 | |
2016-02-19 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
D - Sale to Issuer | −1 250 | 40 265 | −3,01 | ||||
2016-02-19 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −451 | 41 515 | −1,07 | 15,37 | −6 932 | 638 086 | |
2016-02-08 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
A - Award | 22 889 | 22 889 | 15,77 | 360 960 | 360 960 | ||
2016-02-08 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
A - Award | −9 988 | 41 966 | −19,22 | 15,77 | −157 511 | 661 804 | |
2016-02-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −664 | 31 978 | −2,03 | 16,16 | −10 730 | 516 764 | |
2016-02-01 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −529 | 32 642 | −1,59 | 15,97 | −8 448 | 521 293 | |
2016-02-01 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −529 | 32 642 | −1,59 | 15,97 | −8 448 | 521 293 | |
2015-11-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
A - Award | 5 000 | 33 700 | 17,42 | 19,16 | 95 800 | 645 692 | |
2015-08-17 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 1 000 | 9 000 | 12,50 | 13,20 | 13 200 | 118 800 | |
2015-08-17 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 000 | 28 700 | −3,37 | 20,45 | −20 450 | 586 915 | |
2015-08-17 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 1 000 | 29 700 | 3,48 | 13,20 | 13 200 | 392 040 | |
2015-08-10 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 5 000 | 10 000 | 100,00 | 13,20 | 66 000 | 132 000 | |
2015-08-10 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −5 000 | 28 700 | −14,84 | 21,06 | −105 300 | 604 422 | |
2015-08-10 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 5 000 | 33 700 | 17,42 | 13,20 | 66 000 | 444 840 | |
2015-06-09 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 5 000 | 20 000 | 33,33 | 10,43 | 52 150 | 208 600 | |
2015-06-09 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −5 000 | 28 700 | −14,84 | 19,99 | −99 950 | 573 713 | |
2015-06-09 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 5 000 | 33 700 | 17,42 | 10,43 | 52 150 | 351 491 | |
2015-06-05 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −787 | 28 700 | −2,67 | 19,58 | −15 409 | 561 946 | |
2015-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 3 750 | 0 | −100,00 | ||||
2015-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −3 750 | 29 487 | −11,28 | 19,39 | −72 712 | 571 753 | |
2015-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 3 750 | 33 237 | 12,72 | 5,25 | 19 688 | 174 494 | |
2015-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
D - Sale to Issuer | −1 250 | 29 487 | −4,07 | ||||
2015-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −463 | 30 737 | −1,48 | ||||
2015-05-11 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 7 500 | 0 | −100,00 | ||||
2015-05-11 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 7 000 | 0 | −100,00 | ||||
2015-05-11 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −7 500 | 31 200 | −19,38 | 19,20 | −144 000 | 599 040 | |
2015-05-11 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 7 500 | 38 700 | 24,04 | 11,21 | 84 075 | 433 827 | |
2015-05-11 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −7 000 | 31 200 | −18,32 | 19,35 | −135 450 | 603 720 | |
2015-05-11 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 7 000 | 38 200 | 22,44 | 8,90 | 62 300 | 339 980 | |
2015-03-19 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −3 500 | 27 700 | −11,22 | 18,53 | −64 855 | 513 281 | |
2015-03-19 |
|
4/A | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 3 500 | 7 000 | 100,00 | 8,90 | 31 150 | 62 300 | |
2015-03-19 |
|
4/A | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −3 500 | 31 200 | −10,09 | 18,53 | −64 855 | 578 136 | |
2015-03-19 |
|
4/A | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 3 500 | 34 700 | 11,22 | 8,90 | 31 150 | 308 830 | |
2015-03-16 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −441 | 31 200 | −1,39 | 18,79 | −8 286 | 586 248 | |
2015-03-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −721 | 31 641 | −2,23 | 18,30 | −13 194 | 579 030 | |
2015-03-10 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −259 | 32 362 | −0,79 | ||||
2015-03-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
A - Award | 16 280 | 16 280 | 17,05 | 277 574 | 277 574 | ||
2015-03-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
A - Award | 7 530 | 32 621 | 30,01 | 17,05 | 128 386 | 556 188 | |
2015-02-25 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 3 750 | 15 000 | 33,33 | 5,99 | 22 462 | 89 850 | |
2015-02-25 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −3 750 | 25 091 | −13,00 | 16,22 | −60 825 | 406 976 | |
2015-02-25 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 3 750 | 28 841 | 14,95 | 5,99 | 22 462 | 172 758 | |
2015-02-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 5 000 | 7 500 | 200,00 | 2,93 | 14 650 | 21 975 | |
2015-02-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 250 | 25 091 | −4,75 | 16,46 | −20 575 | 412 998 | |
2015-02-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 1 250 | 26 341 | 4,98 | 2,93 | 3 662 | 77 179 | |
2015-02-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −3 750 | 25 091 | −13,00 | 16,60 | −62 250 | 416 511 | |
2015-02-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 3 750 | 28 841 | 14,95 | 2,93 | 10 988 | 84 504 | |
2015-02-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 623 | 25 091 | −6,08 | 16,48 | −26 747 | 413 500 | |
2015-02-19 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
D - Sale to Issuer | −1 250 | 26 714 | −4,47 | ||||
2015-02-19 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −529 | 27 964 | −1,86 | ||||
2015-02-06 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −661 | 28 493 | −2,27 | ||||
2015-02-03 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
D - Sale to Issuer | −1 250 | 29 154 | −4,11 | ||||
2015-02-03 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −529 | 30 404 | −1,71 | ||||
2014-11-18 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Options to Purchase Common Stock |
M - Exercise | 10 500 | 0 | −100,00 | 8,31 | 87 255 | ||
2014-11-18 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −10 500 | 30 933 | −25,34 | 16,06 | −168 630 | 496 784 | |
2014-11-18 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 10 500 | 41 433 | 33,94 | 8,31 | 87 255 | 344 308 | |
2014-11-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Options to Purchase Common Stock |
M - Exercise | 7 500 | 22 500 | 50,00 | 5,99 | 44 925 | 134 775 | |
2014-11-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −7 500 | 30 933 | −19,51 | 17,03 | −127 725 | 526 789 | |
2014-11-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 7 500 | 38 433 | 24,25 | 5,99 | 44 925 | 230 214 | |
2014-09-02 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Options to Purchase Common Stock |
M - Exercise | 1 250 | 3 750 | 50,00 | 5,25 | 6 562 | 19 688 | |
2014-09-02 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 250 | 30 933 | −3,88 | 19,74 | −24 675 | 610 617 | |
2014-09-02 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 1 250 | 32 183 | 4,04 | 5,25 | 6 562 | 168 961 | |
2014-08-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 10 000 | 1 250 | −114,29 | 5,25 | 52 500 | 6 562 | |
2014-08-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −10 000 | 30 933 | −24,43 | 18,99 | −189 900 | 587 418 | |
2014-08-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 10 000 | 40 933 | 32,33 | 5,25 | 52 500 | 214 898 | |
2014-08-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −797 | 30 933 | −2,51 | 18,99 | −15 135 | 587 418 | |
2014-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | 2 500 | 16 250 | 18,18 | 2,93 | 7 325 | 47 612 | |
2014-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −2 500 | 31 730 | −7,30 | 16,93 | −42 325 | 537 189 | |
2014-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | −2 500 | 34 230 | −6,81 | 2,93 | −7 325 | 100 294 | |
2014-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −453 | 31 730 | −1,41 | ||||
2014-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
D - Sale to Issuer | −1 250 | 32 183 | −3,74 | ||||
2014-05-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock |
M - Exercise | −1 250 | 18 750 | −6,25 | 2,93 | −3 662 | 54 938 | |
2014-05-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 250 | 33 433 | −3,60 | 15,45 | −19 312 | 516 540 | |
2014-05-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 1 250 | 34 683 | 3,74 | 2,93 | 3 662 | 101 621 | |
2014-05-13 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock |
M - Exercise | −2 500 | 20 000 | −11,11 | 2,93 | −7 325 | 58 600 | |
2014-05-13 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −2 500 | 33 433 | −6,96 | 15,27 | −38 175 | 510 522 | |
2014-05-13 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 2 500 | 35 933 | 7,48 | 2,93 | 7 325 | 105 284 | |
2014-05-13 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock |
M - Exercise | −2 500 | 22 500 | −10,00 | 2,93 | −7 325 | 65 925 | |
2014-05-13 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −2 500 | 33 433 | −6,96 | 14,80 | −37 000 | 494 808 | |
2014-05-13 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 2 500 | 35 933 | 7,48 | 2,93 | 7 325 | 105 284 | |
2014-05-13 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −897 | 33 433 | −2,61 | 14,80 | −13 276 | 494 808 | |
2014-03-18 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −254 | 34 330 | −0,73 | ||||
2014-03-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −254 | 34 584 | −0,73 | ||||
2014-02-27 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock |
M - Exercise | 3 000 | 0 | −100,00 | 9,34 | 28 020 | ||
2014-02-27 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −3 000 | 34 838 | −7,93 | 15,73 | −47 190 | 548 002 | |
2014-02-27 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 3 000 | 37 838 | 8,61 | 9,34 | 28 020 | 353 407 | |
2014-02-25 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock |
M - Exercise | −2 500 | 25 000 | −9,09 | 2,93 | −7 325 | 73 250 | |
2014-02-25 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −2 500 | 34 838 | −6,70 | 15,19 | −37 975 | 529 189 | |
2014-02-25 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 2 500 | 37 338 | 7,18 | 2,93 | 7 325 | 109 400 | |
2014-02-24 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 500 | 34 838 | −4,13 | 14,87 | −22 305 | 518 041 | |
2014-02-19 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 500 | 36 338 | −3,96 | 13,37 | −20 055 | 485 839 | |
2014-02-19 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −1 038 | 37 838 | −2,67 | ||||
2014-02-06 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock |
A - Award | 25 000 | 25 000 | 10,43 | 260 750 | 260 750 | ||
2014-02-06 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
A - Award | 12 500 | 38 876 | 47,39 | 10,43 | 130 375 | 405 477 | |
2014-02-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −1 038 | 26 376 | −3,79 | ||||
2013-12-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock |
M - Exercise | 2 500 | 27 500 | 10,00 | 2,93 | 7 325 | 80 575 | |
2013-12-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −2 500 | 27 414 | −8,36 | 10,93 | −27 325 | 299 635 | |
2013-12-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
M - Exercise | 2 500 | 29 914 | 9,12 | 2,93 | 7 325 | 87 648 | |
2013-11-22 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −2 300 | 27 414 | −7,74 | 11,55 | −26 565 | 316 632 | |
2013-11-06 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −362 | 29 714 | −1,20 | ||||
2013-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
F - Taxes | −454 | 30 076 | −1,49 | ||||
2013-06-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
D - Sale to Issuer | −1 250 | 30 530 | −3,93 | ||||
2013-05-31 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −800 | 31 780 | −2,46 | 11,26 | −9 008 | 357 843 | |
2013-05-13 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 200 | 32 580 | −3,55 | 10,40 | −12 480 | 338 832 | |
2013-03-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −180 | 33 780 | −0,53 | 9,91 | −1 784 | 334 760 | |
2013-03-20 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −249 | 33 960 | −0,73 | 9,98 | −2 485 | 338 921 | |
2013-03-14 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −677 | 34 209 | −1,94 | 10,75 | −7 278 | 367 747 | |
2013-03-11 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 000 | 34 886 | −2,79 | 9,56 | −9 560 | 333 510 | |
2013-02-26 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −984 | 35 886 | −2,67 | 8,18 | −8 049 | 293 547 | |
2013-02-21 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 000 | 36 870 | −2,64 | 7,89 | −7 890 | 290 904 | |
2013-02-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock |
A - Award | 30 000 | 30 000 | 5,99 | 179 700 | 179 700 | ||
2013-02-04 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
A - Award | 10 000 | 37 870 | 35,88 | 5,99 | 59 900 | 226 841 | |
2012-11-06 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −372 | 27 870 | −1,32 | 3,51 | −1 306 | 97 824 | |
2012-08-27 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −1 000 | 28 242 | −3,42 | 3,22 | −3 220 | 90 939 | |
2012-08-13 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −3 000 | 29 242 | −9,30 | 3,00 | −9 000 | 87 726 | |
2012-06-12 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
D - Sale to Issuer | −1 250 | 32 242 | −3,73 | ||||
2012-06-07 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −504 | 33 492 | −1,48 | 2,28 | −1 149 | 76 362 | |
2012-05-16 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −2 400 | 33 996 | −6,59 | 3,01 | −7 224 | 102 328 | |
2012-03-21 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −205 | 36 396 | −0,56 | 2,80 | −574 | 101 909 | |
2012-03-21 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −873 | 36 601 | −2,33 | 2,75 | −2 401 | 100 653 | |
2012-03-08 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
S - Sale | −91 | 37 474 | −0,24 | 2,66 | −242 | 99 681 | |
2012-02-21 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock |
A - Award | 30 000 | 30 000 | 2,93 | 87 900 | 87 900 | ||
2012-02-21 |
|
4 | AMRI |
ALBANY MOLECULAR RESEARCH INC
Common Stock |
A - Award | 10 000 | 37 565 | 36,28 | 2,93 | 29 300 | 110 065 |